Lario Therapeutics has secured $2.4 million in new grant funding from The Michael J Fox Foundation for Parkinson’s Research ...

New prestigious grants support Lario's unique portfolio of calcium channel programmes -- Indication expansion into Parkinson's disease, and PTSD (post-traumatic stress disorders) -- Builds on prior ...

Here are the latest biotech industry updates: introducing new platforms for SPR, RNA-seq libraries and DNA extraction.

Lario Therapeutics Ltd. has received a total of $2.4 million in grant funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Wellcome to support the continued expansion of its ...

Investing.com -- Upstream Bio (NASDAQ:UPB) stock fell 23% after the company reported mixed results from its Phase 2 VALIANT trial of verekitug for severe asthma treatment.

Lario secures $2.4 million in funding to advance drug discovery for neurological disorders and transform precision medicine.

With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...

Ohio native J.T. Miller represents Team USA in the Olympic hockey semifinal. See game times and how to watch the semis and medal matches.

Ahead of 'Paradise' season 2 (premiering on Hulu February 23, 2026), Nicole Brydon Bloom, Sarah Shahi & Krys Marshall told Brit + Co's Chloe Williams about a super memorable cast dinner and their best ...

The cardiology landscape is rapidly evolving. Novel risk factors and new tools are reshaping CV risk assessment and ...

The presentation by Dr. Dirk Beher, Chief Executive Officer of FundaMental Pharma, will highlight the scientific foundation for lead candidate FMP374, the distinctive approach to modulating NMDAR, and ...

Zealand Pharma announces positive phase 1a top-line results with Kv1.3 channel blocker ZP9830: Copenhagen, Denmark Friday, February 20, 2026, 18:00 Hrs [IST] Zealand Pharma A/S, a ...